Shandong Mingren Furida Pharmaceutical

Mingren Freda Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM), health products, and chemical drugs. As a core subsidiary of the Freda Pharmaceutical Group, the company leverages advanced extraction and preparation technologies to produce a wide range of treatments for orthopedic, respiratory, and gynecological conditions. Their flagship products include the Mingren Freda series of granules and external liniments, which are widely recognized in the domestic Chinese market. The company operates large-scale GMP-certified manufacturing facilities and maintains a strong focus on integrating modern scientific standards with traditional herbal medicine. Mingren Freda is also heavily involved in the development of hyaluronic acid-based health applications, benefiting from its parent group's leadership in the HA industry.